Industry News

Hansa Biopharma signals sharp shift in strategy

Author: Nordic Life Science

Hansa Biopharma is set to cut 20% of its workforce as part of a sweeping restructure aimed at streamlining operations and sharpening its focus. Under new leadership, the company plans to unlock SEK 40–50 million in annual savings by reallocating resources and increasing organisational efficiency. The move reflects a growing trend among biotech firms to recalibrate amid mounting cost pressures and the demand for greater shareholder returns.

Read the full story for insight into what’s driving the shake-up.

Other News